The Pet Diabetes Care Market is expected to register a CAGR of 8.3% over the forecast period.
Major lead players in the market areUltiMed, Boehringer Ingelheim Vetmedica, Merck, Apotex, Zoetis, BD, Henry Schein Animal Health and FitBark.
Dogs and cats with diabetes usually require lifelong treatment with special diets, a good fitness regimen and, particularly in dogs, daily insulin injections. The key to managing diabetic pets is to keep your pet's blood sugar near normal levels and avoid too-high or too-low levels that Can be life threatening.
Insulin treatment for diabetic dogs and cats is the foundation of the care and many types of insulin were shown to be efficient. Insulin reduces blood glucose levels by increasing peripheral consumption of glucose and by suppressing the production of hepatic glucose.
Ultimed Safe Pack, the only dual-purpose system that allows you to dispense a new syringe and safely dispose used syringes without having to purchase a separate sharps container. The patented all-in-one solution is designed for clinic or in-home use. The UltiGuard Safe Pack contains 100 human-grade syringes and is available in 3/10cc, 1/2cc, and 1cc sizes in a variety of needle gauge and lengths with whole or half-unit markings. Aug 2020 Boehringer Ingelheim unveiled a new presentation of PROZINC (protamine zinc recombinant human insulin) with the proven benefit of once-daily dosing in most canine diabetic patients1. Now, with two presentations designed for feline and canine patients, PROZINC is the insulin veterinarians have been waiting for. Once-daily dosing with PROZINC is a breakthrough for pet owners with diabetic dogs.
A single injection can provide consistent and reliable control of clinical signs for 18 to >24 hours in most canine patients. Not only is PROZINC more convenient for dog owners, but it reinforces veterinarians’ commitment to providing a better quality of life for their patients. PROZINC is FDA-approved to reduce hyperglycemia and hyperglycemia-associated clinical signs in dogs. PROZINC is for use in dogs and cats onl
In recognition of World Rabies Day on September 28, 2020 Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced the launch of a global campaign to raise awareness among veterinarians, dog owners and volunteers who are committed to eliminate rabies through ongoing dog vaccination efforts. In partnership with Mission Rabies and Rabies Free Africa, the social media initiative recognizes and celebrates those individuals who are committed to protecting and saving canine as well as human lives, using the hashtag, #ForThemForUs.
May 2020 research- Enhanced Release of Glucose into the Intraluminal Space of the Intestine Associated with Metformin Treatment as Revealed by Fluorodeoxyglucose PET. Among 244 individuals with type 2 diabetes who underwent PET-MRI, we extracted 24 pairs of subjects matched for age, BMI, and HbA1c level who were receiving treatment with metformin (metformin group) or were not (control group). We evaluated accumulation of [18F] FDG in different portions of the intestine with both a visual scale and measurement of maximum standardized uptake value (SUVmax), and such accumulation within the intestinal wall or lumen was discriminated on the basis of SUVmax. June -2020 A research team of Kobe University Graduate School of Medicine's Professor OGAWA Wataru has discovered that metformin, the most widely prescribed anti-diabetic drug, causes sugar to be excreted in the stool. Taking advantage of the new bio-imaging apparatus PET-MRI, they revealed that metformin promotes the excretion of blood sugar from the large intestine into the stool. This is a completely new discovery that was not previously anticipated.
Global Pet Diabetes Care Market, by Drug Type classifies Insulin Therapy and Oral Medication monitoring Devices, Insulin Delivery devices. By animal type it has been Canine, Feline and others. Based on Application it has Veterinary Clinics, Home care and veterinary Clinics. Region wise it divided into North America, Europe, Asia-pacific and Row. The U.S. dominated the global pet diabetes care market in 2018 owing to the largest pet population, high expenditure on pet care, high disposable income as well as the presence of dominant market players in the region. Furthermore, the presence of good animal welfare policies will fuel market growth.
Interested in the Report just Click on below link:
For more information contact @